Answer
No, the safety and efficacy of docetaxel for nasopharyngeal carcinoma in children aged 1 month to under 18 years have not yet been established.
Sources for this answer
- Docetaxel 20 mg/ml concentrate for solution for infusionSeacross Pharmaceuticals Ltd · emc · SmPC §4.2 Posology and method of administration · Version 7Document updated
Sources checked